One of the six women who developed an extremely rare, severe type of blood clot linked to the Johnson & Johnson vaccine is from Pennsylvania.
- --with the debate over what to do with the Johnson and Johnson's one-shot dose of the coronavirus vaccine.
- US health officials still meeting right at this moment, weighing what to do next. This after six rare reports of blood clotting amid more than six million doses administrated. Use of the shot on pause, at least for now.
- Eyewitness News reporter Marcus Solis is live in White Plains. Marcus?
MARCUS SOLIS: Sandra and Bill, some of the nation's top doctors have been discussing this for the better part of the afternoon. That meeting, as you said, still going on. No consensus yet, but there is strong support and talk of extending this pause on the Johnson and Johnson vaccine because there are more questions than answers.
- Hello. If you have an appointment, have your appointment confirmation out.
MARCUS SOLIS: It's all Pfizer, all the time at this mass vaccination site in White Plains and where some newly scheduled appointments will accommodate those who were supposed to receive the Johnson and Johnson shot. That vaccine put on hold by the CDC and the FDA to further examine the potential link to dangerous blood clots and to find common symptoms that doctors should be on the lookout for.
ANNE SCHUCHAT: I can't say how long the pause will last. But a key component of why we are on this pause is so that we can educate the clinicians about how to diagnose and treat this condition, because the usual treatment could actually make things worse.
MARCUS SOLIS: 6.8 million doses of the J&J vaccine have been administered in the United States. There have been six cases where women between 18 and 48 years old developed clots that prevented blood from draining from the brain. The condition developing 6 to 13 days after being inoculated. One patient died.
Still, health officials stress the cases are incredibly rare-- less than one in a million.
ANNE SCHUCHAT: If you got the vaccine more than three weeks ago and you're feeling fine, you really have an extremely low risk and don't need to be concerned.
MARCUS SOLIS: And guidance will go out, however, to doctors to be on the lookout for certain symptoms among those who have been recently inoculated. Symptoms including a persistent headache and abdominal pain. Again, no consensus reached as this meeting continues on, but it does appear that the inclination is to extend this Johnson and Johnson pause.
We will, of course, have much more for you in another live report at 6:00. For now--